1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Global HPV Testing Market 2016-2020

Global HPV Testing Market 2016-2020

  • December 2016
  • -
  • Infiniti Research Limited
  • -
  • 80 pages

Summary

Table of Contents

Search Inside

About HPV Testing

According to Centers for Disease Control and Prevention (CDC), human papillomavirus (HPV) refers to a group of more than 100 related viruses that commonly cause infections and do not have any symptoms. Among these, more than 40 types of HPVs cause highly contagious diseases that are transmitted through direct sexual contact, infecting both male and female genitals. The other types of HPV cause non-genital warts that are not sexually transmitted. Though most HPV infections are harmless and heal on their own, certain high-risk types of genital HPV can be persistent and cause cervical, penile, anal, vaginal, and oropharyngeal cancers. Many individuals, especially women, undergo regular HPV tests as a preventive measure. HPV tests help to detect the viral genetic material in a cell sample taken from the cervix.

Technavio’s analysts forecast the global HPV testing market to grow at a CAGR of 16.17% during the period 2016-2020.


Covered in this report
The report covers the present scenario and the growth prospects of the global HPV testing market for 2016-2020. To calculate the market size, the report considers only the HPV test products used for genital cancer screening such as cervical cancer.


The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Technavio's report, Global HPV Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.


Key vendors
- Abbott Laboratories
- BD
- Roche Diagnostics
- Qiagen


Other prominent vendors
- Arbor Vita
- Breakspear Medical
- Cepheid
- DAAN Gene
- DiaCarta
- Delphi Bioscience
- Fujirebio Diagnostics
- Genera Biosystems
- IncellDx
- OralDNA Labs
- Seegene
- SoloPap
- Trovagene


Market driver
- Early detection of cervical cancer to prevent the growing prevalence
- For a full, detailed list, view our report


Market challenge
- Pap test: Alternative diagnostic tests for cervical cancer screening
- For a full, detailed list, view our report


Market trend
- Expansion of companies in key markets
- For a full, detailed list, view our report


Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.






Methodology
Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017-2021 World Sexually-Transmitted Disease (STD) Diagnostics Market: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis--Supplier Shares, Sales Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation

2017-2021 World Sexually-Transmitted Disease (STD) Diagnostics Market: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis--Supplier Shares, Sales Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation

  • $ 9600
  • Industry report
  • January 2017
  • by Venture Planning Group

About this Report This report presents a detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan.  Current scientific views on epidemiology and etiology are ...

2017 Competing in the Global Sexually-Transmitted Disease (STD)Testing Market

2017 Competing in the Global Sexually-Transmitted Disease (STD)Testing Market

  • $ 9600
  • Industry report
  • March 2017
  • by Venture Planning Group

Complete report $9,600.  DataPack (test volumes, sales forecasts, supplier shares) $6,200. This new 350-page report from VPGMarketResearch.com contains 90 tables and provides analysis of the global s ...

2017-2021 Sexually-Transmitted Diseases (STD) Diagnostic Testing Market

2017-2021 Sexually-Transmitted Diseases (STD) Diagnostic Testing Market

  • $ 6200
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $9,600.  DataPack (test volumes, sales forecasts, supplier shares) $6,200. This new 350-page report from VPGMarketResearch.com contains 90 tables and provides analysis of the global s ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.